Walleye Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
37,218
+16,447
| +79% | +$632K | 0.01% | 725 |
|
|
2025
Q1 | $805K | Sell |
20,771
-7,199
| -26% | -$279K | ﹤0.01% | 911 |
|
|
2024
Q4 | $946K | Buy |
27,970
+18,696
| +202% | +$632K | ﹤0.01% | 955 |
|
|
2024
Q3 | $379K | Sell |
9,274
-192,298
| -95% | -$7.86M | ﹤0.01% | 1459 |
|
|
2024
Q2 | $7.76M | Buy |
201,572
+199,629
| +10,274% | +$7.69M | 0.01% | 347 |
|
|
2024
Q1 | $83.3K | Sell |
1,943
-18,274
| -90% | -$783K | ﹤0.01% | 2052 |
|
|
2023
Q4 | $749K | Buy |
+20,217
| New | +$749K | ﹤0.01% | 1012 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2545 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2386 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2378 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2320 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2466 |
|
|
2018
Q3 | $1.21M | Buy |
+23,994
| New | +$1.21M | 0.56% | 43 |
|